Submit Entry |  Bio-IT World Conference & Expo |  Sponsorship   

Bio-IT World Best Practices Awards

Celebrating Excellence in Innovation 

The 2013 Bio-IT World Best Practices competition has released its call for entries. The deadline for entry is February 11, 2013 

Bio-IT World has held the Best Practices awards since 2003, highlighting outstanding examples of technology innovation in the life sciences, from basic R&D to translational medicine. We particularly encourage vendors to nominate entries from valued academic and/or industry partners.

Submitting your organization’s entry is straightforward:
• Send us a brief overview of your technology, including a statement of the issue or problem at hand, the innovative approach or technology applied, and the ROI (Return on Investment) in terms of scientific insights, cost savings, productivity, etc. (entry form and full details here)
• Entries will be accepted until February 11, 2013.
• All entries will be judged by an expert panel in February/March 2013.
• Winners will be announced in a plenary session at Bio-IT World Conference & Expo, Boston, April 10, 2013.
• All winners will be featured in follow-up profiles in Bio-IT World.

Please send entries or direct any questions to Bio-IT World Managing Editor, Allison Proffitt.

 
The 2012 Bio-IT World Best Practice Winners were announced at the 2012 Bio-IT World Conference & Expo, World Trade Center in Boston, MA, USA.   

2012 Winners: 

Clinical & Health IT: PFIZER   

Pfizer REMOTE Virtual Clinical Trial Pilot—Novel Technology Integration to Improve Clinical Trial Access and Convenience (Work done in conjunction with the University of California, San Francisco; Mytrus; ExcoInTouch; Perceptive Informatics; and Greenphire) 

The first‐ever clinical trial under an IND that employs a new Participatory Patient-Centered (PPC) model, allowing patients to be recruited and participate remotely, regardless of proximity to clinical sites, and to receive results that can be incorporated into personal health records. 

Informatics: MERCK & Co.   

Replacing Traditional Fetal Skeletal Evaluations in Reproductive Toxicology Utilizing Micro-CT Imaging 

Initiative to replace traditional inspections of stained skeletons with digital images from micro‐computed tomography studies, an important aspect of preclinical safety studies. 

IT Infrastructure: BGI SHENZHEN BIOINFORMATICS CENTER, CHINA    

A Flexible Green Cloud Computing Framework for Genome de novo Assembly and Re-sequencing Analysis 

The development of two high-performance cloud-compatible software tools, Hecate and Gaea, for de novo mammalian genome assembly, sequence alignment and biomarker discovery, and used by BGI and its many collaborators.  

Knowledge Management: MERCK KGaA (Darmstadt, Germany)   

Innospire 

A ‘wisdom of the crowds’ program to mobilize the innovation potential of all Merck KGaA employees for generation of new innovative products, resulting in nearly a dozen new initiatives thus far 

Personalized & Translational Medicine: UNIVERSITY of UTAH and OMICIA Inc.   

VAAST: a probabilistic disease—gene finder for personal genomes 

A novel algorithm to identify disease-causing mutations combining predictive and frequency information, proven in the identification of the gene for Ogden Syndrome. 

Judges’ Prize: BRISTOL-MYERS SQUIBB   

Leveraging ELN (electronic lab notebooks) to Improve Chemistry Lab Safety 

A novel ELN-based approach to efficiently push safety alerts to research chemists and safety committees and flag ‘near miss’ accidents to prevent more serious incidents 

Editors’ Choice Award: MEDICAL COLLEGE of WISCONSIN (Liz Worthey & her colleagues)   

Carpe Novo 

A special award for Carpe Novo, an in-house clinical genome informatics solution for studying the DNA sequence of patients to identify causative mutations and end diagnostic odysseys. 

Press Release |  Testimonials  |  Photo Gallery